12.11.2024  21:50:38 Zm. - Wolumen Bid22:00:00 Ask22:00:00 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
202,40EUR - 165
Obrót: 33 661,20
194,55Wolumen Bid: 29 196,60Wolumen Ask: 28 9,94 mldEUR - -

Opis działalności

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
 

Zarząd & Rada nadzorcza

CEO
James C. Foster
Zarząd
Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson
Rada nadzorcza
James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson
 

Dane firmy

Nazwa: Charles River Laboratories International, Inc.
Adres: 251 Ballardvale Street,Wilmington, Massachusetts 01887, USA
Telefon: +1-781-222-6000
Fax: -
E-mail: -
Internet: www.criver.com
Przemysł: Biotechnologia
Sektor: Biotechnologia
Podsektor: Biotechnologia
Koniec roku finansowego: 31.12
Free float: 88,30%
Data IPO: 23.06.2000

Relacje inwestorskie

Nazwa: -
Telefon: +1-781-222-6190
Fax: -
E-mail: askcharlesriver@crl.com